RESULTS	None of the 44 patients in remission at 6 or 12 months became permanently work disabled over the 5-year followup , as compared with 15 patients in the ACR50 group ( 23 % ) , 6 in the ACR20 group ( 21 % ) , and 19 without an ACR20 response at 6 months ( 56 % ) .\